ATAT vs TSLA

ATAT exhibits exceptional deterministic health with a perfect Piotroski F-Score of 9/9, signaling strong financial quality and operational efficiency. The company's robust profitability metrics—ROE of 49.68%, gross margin of 44.26%, and 33.8% YoY revenue growth—demonstrate superior execution in a cyclical sector. Despite a lack of Altman Z-Score, the low debt/equity ratio (0.43) and strong liquidity (current ratio 1.97) support financial stability. The stock trades below its intrinsic value of $49.85 and Graham Number of $11.99, suggesting significant upside potential, especially given its strong analyst consensus and 214.2% Q/Q EPS growth. However, inconsistent earnings surprises and a bearish technical trend introduce near-term volatility risk.

Tesla's deterministic health is marginally stable with a Piotroski F-Score of 4/9, but the valuation is fundamentally decoupled from financial performance. The stock trades at a massive premium to its Graham Number ($23.07) and Intrinsic Value ($7.56), while exhibiting negative revenue growth (-3.10%) and a severe collapse in earnings growth (-60.60%). With zero earnings beats in the last four quarters and bearish insider activity, the current price is supported by sentiment rather than data.